Valuation: Aprogen Medicines Inc.

Market Cap 43.87B 32.9M 29.25M 27.11M 24.66M 46.54M 3.12B 47.29M 326M 128M 1.63B 123M 121M 5.19B P/E 2024
-3.44x
P/E 2025 -2.95x
Enterprise Value 181B 136M 121M 112M 102M 192M 12.88B 195M 1.34B 527M 6.72B 509M 499M 21.43B EV / Sales 2024
1.93x
EV / Sales 2025 2.99x
Free-Float
81.19%
Yield 2024 *
-
Yield 2025 -
09-22 Aprogen Biologics Inc. announced that it has received KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
09-22 Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
09-21 Aprogen Medicines Inc.(KOSE:A007460) dropped from S&P Global BMI Index CI
09-03 Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
09-02 Aprogen Biologics Inc. announced that it expects to receive KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
08-21 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding from Jade New Technology Association CI
08-14 Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-09 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding from Jade New Technology Association CI
07-26 Aprogen Biologics Inc. announced that it has received KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-23 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding CI
07-14 Aprogen Medicines to Raise 2 Billion Won Through Convertible Bond Issue MT
07-13 Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
07-13 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding CI
1 day+0.96%
1 week-3.90%
Current month+3.53%
1 month-0.20%
3 months-13.30%
6 months-54.63%
Current year-80.93%
1 week 1,895
Extreme 1895
2,060
1 month 1,875
Extreme 1875
2,335
Current year 1,875
Extreme 1875
11,880
1 year 1,875
Extreme 1875
14,070
3 years 1,875
Extreme 1875
28,410
5 years 1,875
Extreme 1875
94,950
10 years 1,875
Extreme 1875
875,250
Manager TitleAgeSince
Chief Executive Officer 63 26/12/2017
Comptroller/Controller/Auditor 69 27/03/2018
Director TitleAgeSince
Director/Board Member 63 28/11/2022
Director/Board Member 64 17/07/2022
Director/Board Member 62 12/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
17/01/25 Others 7,673 0.0025% -
19/01/24 Free 101,429 0.0383%
19/01/24 Free 198,187 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%-3.90%-78.14%-87.46% 32.9M
+0.17%+0.08%+31.32%+154.19% 121B
-3.08%-7.84%+18.45%+37.15% 95.61B
-0.04%+3.17%+39.34%+86.93% 62.68B
+1.27%+0.53%+20.16%+73.57% 58.53B
-3.18%-13.47%+104.21%+162.84% 56.39B
-0.68%-2.57%+33.59%+50.23% 35.39B
+2.11%+2.59%+46.15%+90.95% 30.46B
-0.12%-1.23%+0.73%+24.67% 30.18B
-1.80%-9.14%+32.40%-8.46% 26.94B
Average -0.44%-1.89%+24.82%+58.46% 51.77B
Weighted average by Cap. -0.77%-2.12%+35.88%+89.40%

Financials

2024 2025
Net sales 150B 113M 100M 92.77M 84.4M 159M 10.69B 162M 1.12B 437M 5.58B 423M 414M 17.78B 118B 88.49M 78.66M 72.9M 66.33M 125M 8.4B 127M 876M 344M 4.38B 332M 325M 13.97B
Net income -58.08B -43.56M -38.72M -35.89M -32.65M -61.62M -4.13B -62.61M -431M -169M -2.16B -163M -160M -6.88B -70.2B -52.66M -46.81M -43.38M -39.47M -74.48M -5B -75.68M -521M -204M -2.61B -198M -193M -8.31B
Net Debt 70.04B 52.54M 46.7M 43.28M 39.38M 74.31M 4.99B 75.5M 520M 204M 2.6B 197M 193M 8.29B 137B 103M 91.41M 84.73M 77.09M 145M 9.76B 148M 1.02B 399M 5.09B 386M 378M 16.24B
Projected Income Statement - Annual - Aprogen Medicines Inc.
Logo Aprogen Medicines Inc.
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Employees
160
Date Price Change Volume
18/10/26 ₩1,994.00 +0.96% 52,439
16/10/26 ₩1,975.00 +3.24% 78,636
15/10/26 ₩1,913.00 -4.25% 121,958
14/10/26 ₩1,998.00 +2.72% 107,700
13/10/26 ₩1,945.00 -1.27% 199,952
  1. Stock Market
  2. Stocks
  3. A007460 Stock